Tag: brian rini

RCC_650x450
January 30, 2019/Research

Survival Rates Higher for Patients with Metastatic Renal Cancer at High-Volume Facilities

Study first to compare rates for mRCC medical oncology

Renal-Cell-Carcinoma_650x450
October 24, 2018/Research

IMmotion Update: Understanding the Biomarkers Behind Better Outcomes

Gene signatures differentiate clinical response

RCC-multi_650x450
June 11, 2018/Research

Multigene Assay Holds Prognostic Promise for Renal Cell Carcinoma

Identifying low and high risk of recurrence

650×450-Renal-Cell-Carcinoma
June 3, 2018/Research

IMmotion151 Reports Encouraging Results

New mRCC medication regimen effective and well tolerated

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

RCC_650x450
May 14, 2018/Research

Two Clinical Trials of Advanced Renal Cell Carcinoma Therapies Report Positive Results

Standard of care is changing and may lead to better clinical outcomes

renal-cell-cance_650x450
March 21, 2018/Research

Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer

Positive results point to a better prognosis for intractable disease

Lab_650x450
January 3, 2018/Research

Next-Generation Sequencing of Tumor Tissue Versus Blood in Patients with Advanced Urothelial Cancer

Study examines concordance between commercially available genomic tests

Dr.-Rini_650x450
May 10, 2017/News & Insight

Brian Rini, MD, Chairs Session on Genitourinary Cancers

State of the Science Summit on May 18

Picture2_650x450
September 12, 2016/Research

Study Shows Active Surveillance is Safe and Viable in Some Metastatic Renal Cell Carcinoma Patients

Survival for months or several years while delaying treatment is possible

BackPage 1 of 2Next
Advertisement
Ad